OpenResearchAlpha

Endoscopy · 16 Nov 2026

Externally anchored fully covered metal stents with plastic stent versus uncovered metal stents for unresectable distal malignant biliary obstruction: a multicenter randomized trial

Jin Ho Choi, Junyeol Kim, Woo Hyun Paik, In Rae Cho, Ji Kon Ryu, Sung Yong Han, Seong-Hun Kim, Eaum Seok Lee, Sang Myung Woo, Min Kyu Jung, Joung-Ho Han, Eunae Cho, Joo Seong Kim, Dong-Won Ahn, Sang Hyub Leeh-index 39

0
Citations
no database records one yet
0
Citations in 2026
so far
39
Leading author's h-index
Sang Hyub Lee, in QAI's scholar index
28
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Self-expandable metal stents (SEMS) are commonly used to treat malignant biliary obstruction (MBO). External plastic stent anchoring for fully covered SEMS (FCSEMS-EPS) has shown potential to improve stent patency; however, randomized evidence comparing this strategy with uncovered SEMS (USEMS) is limited. This multicenter trial was conducted at nine tertiary referral centers in South Korea. Patients were enrolled from October 2021 to February 2024 and followed for 12 months after stent placement. Those with unresectable distal MBO were randomly assigned (1:1) to receive either FCSEMS-EPS or USEMS. The primary outcome was biliary stent dysfunction. Time-to-event analyses were performed using time to stent dysfunction within a competing risk framework. 113 patients were enrolled, of whom 99 were included in the final analysis (FCSEMS-EPS 48; USEMS 51). Stent dysfunction occurred less frequently in the FCSEMS-EPS group compared with the USEMS group (27.1% vs. 49.0%; P = 0.04). The cumulative incidence of stent dysfunction at 6 months was lower in the FCSEMS-EPS group (21.1% vs. 29.8%; Gray’s test, P = 0.03). In multivariable competing risk analysis, FCSEMS-EPS was independently associated with a lower risk of stent dysfunction (subdistribution hazard ratio 0.44, 95%CI 0.21–0.90; P = 0.03). Procedure-related adverse events and overall survival did not differ between groups. FCSEMS-EPS significantly reduced stent dysfunction compared with USEMS without increasing adverse events, supporting its effectiveness and safety as long-term biliary drainage in unresectable MBO.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Sang Hyub Lee has the highest h-index among the authors (39).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (15)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (28)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 8 more references

A free account opens the rest of the citing papers and references on every paper’s page.